By Sabela Ojea

RUA Life Sciences PLC said Wednesday that the RUA Vascular business has submitted its premarket notification for a range of polymerically sealed vascular grafts to the U.S. Food and Drug Administration.

The developer of polymer materials for medical devices said the submission follows an introduction of the RUA graft at the recent annual meeting of the European Association for Cardio-Thoracic Surgery, held in Barcelona, Spain.

Shares at 0912 GMT were up 10.00 pence, or 6.6%, at 161.50 pence.

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

(END) Dow Jones Newswires

November 03, 2021 05:33 ET (09:33 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Aortech (LSE:AOR)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse Aortech
Aortech (LSE:AOR)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse Aortech